Author: admin

  • 'Buck Moon' stuns UAE skies: See summer’s first full moon illuminates skies worldwide – Gulf News

    'Buck Moon' stuns UAE skies: See summer’s first full moon illuminates skies worldwide – Gulf News

    1. ‘Buck Moon’ stuns UAE skies: See summer’s first full moon illuminates skies worldwide  Gulf News
    2. July full moon 2025 rises this week — Here’s what to expect from the ‘Buck Moon’  Space
    3. How to spot July’s low-rise ‘Buck Moon’, the farthest full moon from the sun in 2025  Live Science
    4. Full moon seen in some parts of world  Xinhua
    5. Look: Buck Moon spotted in UAE skies, marking first full moon of summer  Khaleej Times

    Continue Reading

  • AI is helping to develop gentically engineered food for long-term space missions. We may all benefit – Genetic Literacy Project

    1. AI is helping to develop gentically engineered food for long-term space missions. We may all benefit  Genetic Literacy Project
    2. Scientists working how to grow rice on Moon, Mars  Dunya News
    3. Moon-Rice Could Soon Sprout in Space, Adding a Fresh Ingredient to Astronauts’ Diets  Discover Magazine
    4. Moon-Rice: Developing the perfect crop for space-bases  EurekAlert!
    5. Moon-rice: Super-dwarf plant developed to feed astronauts on deep space missions  Interesting Engineering

    Continue Reading

  • In seconds, AI builds proteins to battle cancer and antibiotic resistance

    In seconds, AI builds proteins to battle cancer and antibiotic resistance

    In the last year, there has been a surge in proteins developed by AI that will eventually be used in the treatment of everything from snakebites to cancer. What would normally take decades for a scientist to create — a custom-made protein for a particular disease — can now be done in seconds.

    For the first time, Australian scientists have used Artificial Intelligence (AI) to generate a ready-to-use biological protein, in this case, one that can kill antibiotic resistant bacteria like E. coli.

    This study, published in Nature Communications, provides a new way to combat the growing crisis caused by antibiotic resistant super bugs. By using AI in this way, Australian science has now joined countries like the US and China having developed AI platforms capable of rapidly generating thousands of ready-to-use proteins, paving the way for faster, more affordable drug development and diagnostics that could transform biomedical research and patient care.

    The Nature Communications paper is co-led by Dr. Rhys Grinter and Associate Professor Gavin Knott, a Snow Medical Fellow, who lead the new AI Protein Design Program with nodes at the University of Melbourne Bio21 Institute and Monash Biomedicine Discovery Institute.

    According to Dr. Grinter and A/Prof. Knott, the AI Protein Design Platform used in this work is the first in Australia that models the work done by David Baker (who won the Nobel Prize in Chemistry last year) developing an end-to-end approach that could create a wide range of proteins. “These proteins are now being developed as pharmaceuticals, vaccines, nanomaterials and tiny sensors, with many other applications yet to be tested” Associate Professor Knott said.

    For this study, the AI Protein Design Platform used AI-driven protein design tools that are freely available for scientists everywhere. “It’s important to democratize protein design so that the whole world has the ability to leverage these tools,” said Daniel Fox, the PhD student who performed most of the experimental work for the study. “Using these tools and those we are developing in-house, we can engineer proteins to bind a specific target site or ligand, as inhibitors, agonists or antagonists, or engineered enzymes with improved activity and stability.”

    According to Dr Grinter, currently proteins used in the treatment of diseases like cancer or infections are derived from nature and repurposed through rational design or in vitro evolution and selection. “These new methods in deep learning enable efficient de novo design of proteins with specific characteristics and functions, lowering the cost and accelerating the development of novel protein binders and engineered enzymes,” he said.

    Since the work of David Baker, new tools and software are being developed, such as Bindcraft and Chai which have been incorporated into an AI Protein Design Platform co-led by Dr. Grinter and A/Prof. Knott..

    Professor John Carroll, Director of the Monash Biomedicine Discovery Institute, said the new AI Protein Design Program ‘brings Australia “right up to speed in this exciting new modality for designing novel therapeutics and research tools. It is testament to the entrepreneurial spirit of two fabulous young scientists who have worked night and day to build this capability from scratch.”

    “The Program, based at Monash University and the University of Melbourne, is run by a team of talented structural biologists and computer scientists who understand the design process from end-to-end. This in-depth knowledge of protein structure and machine learning makes us a highly agile program capable of regularly onboarding cutting edge tools in AI-protein design,” Associate Professor Knott said.

    Continue Reading

  • A novel nomogram to differentiate between renal tuberculosis and nontu

    A novel nomogram to differentiate between renal tuberculosis and nontu

    Department of Urology, Hangzhou Red Cross Hospital, Hangzhou, People’s Republic of China

    Correspondence: Yong Qin, Department of Urology, Hangzhou Red Cross Hospital, 208 East Huancheng Road, Hangzhou, 310003, People’s Republic of China, Tel +86571-56108764, Email [email protected]

    Background: To build a diagnostic nomogram for differentiating between renal tuberculosis (RTB) and nontuberculous renal infection.
    Methods: Eligible patients were randomly categorized into derivation and validation cohorts (7:3). Univariate and multivariate regression analyses were conducted to filter variables and select predictors. Multivariate logistic regression was employed for model construction and nomogram were used for visualization. The nomogram was evaluated by Concordance index (C-index), calibration curves and decision curve analysis (DCA).
    Results: Overall, 194 patients were included. The derivation and validation cohorts included 75 and 61 patients and 32 and 26 patients with RTB and nontuberculous renal infection, respectively. We included previous TB history, CRP levels, fever, chronic infection and hydronephrosis in the construction of the nomogram. A nomogram was developed and validated. This nomogram exhibited good discrimination and calibration. The C-indices of this nomogram in the derivation and validation cohorts was 0.99 and 0.98 (95% confidence intervals, 0.97– 1.00 and 0.96– 1.01), respectively. DCA revealed that the proposed nomogram was useful for the differentiation.
    Conclusion: The nomogram can differentiate between RTB and nontuberculous renal infection.

    Keywords: diagnostic nomogram, renal tuberculosis, nontuberculous renal infection, decision curve analysis

    Introduction

    Tuberculosis (TB) is an infectious disease caused by Mycobacterium tuberculosis (MTB). Presently, TB constitutes one of the top 10 causes of death globally.1 In 2021, the mortality rate associated with TB increased for the first time in 9 years.2 TB remains a serious threat to public health. Although it typically affects the lungs (pulmonary tuberculosis [PTB]), it can also affect other organs (extrapulmonary tuberculosis [EPTB]).3 Urogenital tuberculosis (UGTB) is the second most common form of EPTB, representing ~27% of EPTBs.4 In developed countries, UGTB accounts for 2–10% of PTB cases, whereas the figure is 15–20% in developing countries.5–8 Renal tuberculosis (RTB) constitutes the most common form of UGTB.9 The clinical symptoms of RTB are non-specific, which is one of the most important reasons for delaying its diagnosis. For a long period, RTB diagnosis depended on the determination of acid-fast bacilli (AFB) in smears and urine MTB cultures. These bacteriological methods are either slow or have low sensitivity, especially while using clinical specimens such as urine that contain only a small number of microorganisms.10 Therefore, effectively improving the probability of early RTB diagnosis remains challenging. Owing to the lack of sufficient clinical experience and specific detection methods, the misdiagnosis rate of RTB in primary hospitals is particularly high. Therefore, a predictive model to distinguish between RTB and nontuberculous renal infection need to be developed to help clinicians make judgments.

    This retrospective study aimed to establish a diagnostic prediction model visualized via a nomogram to improve the accuracy and practicality of the differential diagnosis of RTB and nontuberculous renal infection.

    Materials and Methods

    Study Design and Patients

    This study included consecutive patients with RTB and nontuberculous renal infection treated in Hangzhou Red Cross Hospital from January 2014 to December 2023. All patients were >18 years. Diagnosis of RTB was established when one of the following criteria was met: effective anti-TB treatment, positive MTB culture, or histopathological diagnosis. Diagnosis of nontuberculous renal infection was based on when one of the following criteria was met: effective antibiotic treatment, positive bacterial culture, or histopathological diagnosis of nontuberculous renal infection. This study included the epidemiological characteristics, clinical symptoms, laboratory test results and Imaging examination results (Ultrasound examination or CT scan) of patients. Demographic characteristics included: sex, age, diagnosis of diabetes, body mass index (BMI), immigrant status, previous TB history, smoking status, alcohol use. Clinical symptoms included: flank pain, lower urinary tract symptoms (LUTS), fever, gross hematuria, chronic infection. Laboratory test results included: positive urine leukocyte, positive urine nitrite, C-reactive protein (CRP) levels. Imaging examination results included: urinary tract stone and hydronephrosis. If patients have missing case data as mentioned above, they will be excluded from this study. This study was approved by the Human Research Ethics Committee of Hangzhou Red Cross Hospital.

    Definition of Variables

    Diagnosis of diabetes was accorded with the World Health Organization (WHO) criteria.11 Patients whose registered residence is not in Zhejiang were defined as immigrants. LUTS mainly referred to symptoms that included frequency, urgency, and dysuria. Chronic infection was defined as disease duration exceeding 3 months. Positive urine leukocyte and urine nitrite were identified via routine urine tests.

    Data Analysis and Model Construction

    R version 4.1.2 was used for statistical analysis. Categorical variables were expressed as frequencies and percentages (%). Continuous variables were expressed as mean ± standard deviation or median and range depending on the data distribution.

    The patients were randomly categorized in a ratio of 7:3 into the derivation and validation cohorts. The derivation cohort was used to filter variables and construct the model, and the validation cohort was used to validate the model. The prediction model was developed using a two-step approach. In step one, univariable and multivariable logistic regression analysis was performed. Variables with P <0.05 in the univariable logistic regression analysis were included in multivariable logistic regression analysis. Following multivariable analysis, variables with P <0.05 were employed to further construct the model. Step two involved multivariable logistic regression analysis to calculate the odds ratio (OR) of each candidate variable and construct the predictive model, and evaluate multicollinearity through variance inflation factor (VIF). The model was visualized by constructing nomograph. The model was validated in the derivation and validation cohorts. The discrimination (C-index) and calibration (calibration curves and P value in the Hosmer–Lemeshow test) of the model were evaluated using the derivation and validation cohorts, respectively, and the performance of the model was comprehensively evaluated. Furthermore, decision curve analysis (DCA) of the model was performed.

    Results

    Finally, 194 patients were included in this study, of whom 107 had RTB and 87 had nontuberculous renal infection. The baseline characteristics of the patients are provided in Table 1. Of the 107 RTB patients, 30 were diagnosed by MTB culture, 17 by histopathology, and 60 by effective anti TB treatment. Of the 87 nontuberculous renal infection patients, 28 were diagnosed by bacterial culture, 1 by histopathology, and 58 by effective antibiotic treatment. The patients were randomly categorized into the derivation and validation cohorts. The former included 75 and 61 patients with RTB and nontuberculous renal infection (n = 136), and the latter included 32 and 26 patients with RTB and nontuberculous renal infection (n = 58), respectively.

    Table 1 Patient Characteristics

    First, univariable analysis of the derivation cohort was performed. The following variables were included in the subsequent multivariable analysis: BMI, previous TB history, chronic infection, fever, sex, immigrant status, flank pain, CRP levels, urinary tract stone and hydronephrosis. Further multivariable regression analysis revealed that the final variables included in the prediction model were previous TB history, CRP levels, fever, chronic infection and hydronephrosis (Table 2). We included previous TB history, CRP levels, fever, chronic infection and hydronephrosis in the construction of the nomogram (Figure 1). Each variable is assigned different points based on the results through the nomogram. Different points can be assigned based on the different results of each variable. The total points were obtained by adding up the points of each variable. The OR value of each variable is shown in Table 3. The discrimination of the nomogram was validated in the derivation and validation cohorts. When the nomogram was used in the derivation cohort, the C-index was 0.99 (95% CI = 0.97–1.00), whereas in the validation cohort, the C-index was 0.98 (95% CI = 0.96–1.01). And the Hosmer–Lemeshow test yielded nonsignificant P values of 0.816 and 0.818 in the derivation and validation cohorts, respectively. This indicates that in both the derivation and validation cohorts, the calibration curve of the model demonstrated high consistencies between the predicted and observed values. The proposed model was well-calibrated (Figure 2).

    Table 2 Results of the Univariable and Multivariable Regression Analysis of the Derivation Cohort

    Table 3 Predictors for the Nomogram

    Figure 1 Nomogram for differentiate between RTB and nontuberculous renal infection. Recommended probability threshold of liner predictor: 0.805.

    Figure 2 Calibration curves of the nomogram. (A) derivation cohort; (B) validation cohort. The vertical axis represents the actual renal tuberculosis rate, and the horizontal axis represents the predicted renal tuberculosis risk. The line Ideal represents the ideal situation where the predicted probability is always equal to the actual probability, line Apparel represents the consistency between the calculated risk probability based on this model and the actual probability, bias-corrected refers to the result of bootstrap-resampling of the data used to construct the model. The Hosmer–Lemeshow test, P>0.05, suggesting that it is of goodness-of-fit.

    Moreover, DCA was conducted to assess the clinical usefulness of the nomogram. The results revealed that using the proposed nomogram to differentiate between RTB and nontuberculous renal infection would obtain a net benefit for nearly all threshold probabilities in both the derivation and validation cohorts (Figure 3).

    Figure 3 Decision curves analysis of the nomogram. (A) derivation cohort; (B) validation cohort. The vertical axis represents the net benefit obtained by subtracting the patient’s risk from the patient’s benefit; the horizontal axis represents the threshold probability. Line None represents the net benefit for all patients with nontuberculous renal infection, line All represents the net benefit for all patients with renal tuberculosis, line Model 1 represents the overall net benefit of the prediction model within the threshold range.

    Discussion

    UGTB is one of the most common EPTBs, accounting for approximately 30%–40% of all EPTB cases.12 UGTB is often secondary to PTB or EPTB of other organs. The interval between secondary UGTB and initial PTB or EPTB diagnosis can be as long as 30 years.13 2–20% of PTB patients develop UGTB through hematogenous spread to the kidneys, prostate, and epididymis.3 Diagnosis of EPTB is difficult due to the difficulty in obtaining test samples.14 Similarly, the clinical diagnosis of RTB remains challenging. Delayed diagnosis of RTB seriously threatens the physical and mental health of patients. MTB may spread to the ureter and bladder through urine.15 As shown in Table 1, RTB and nontuberculous renal infection have similar clinical manifestations. Patients with renal tuberculosis have a higher probability of developing hydronephrosis. The number of male and female patients with RTB is similar, while the proportion of female patients with nontuberculous renal infection is higher. The clinical characteristics of RTB become atypical because of various reasons such as the abuse of quinolone drugs, which increases the difficulty of early diagnosis of RTB.9 The diagnosis of RTB often depends on the determination of AFB in smears and MTB cultures. However, MTB and nontuberculous Mycobacterium both produce positive AFB smears.16 Waiting for the results of MTB culture takes a long time, which is not conducive to the rapid diagnosis of RTB. Recently, molecular biology technology has been widely used for diagnosing TB. A study which used MTB culture as the gold standard found the sensitivity and specificity of Xpert MTB/RIF assay in PTB diagnosis were 92.2% and 99.2%, respectively.17 Xpert MTB/RIF assay and other molecular biological techniques have also been used for RTB diagnosis, thereby improved early diagnosis rate of RTB.18,19 However, some primary hospitals may delay treatment owing to the lack of relevant experience and medical equipment. In recent years, biosensors have been constructed through modern integrated technologies, such as the combination of analytical chemistry, molecular biology, and nanotechnology. Integrated technology enhances the detection of highly selective, specific, and sensitive signals for detecting Mycobacterium tuberculosis.20

    Nomograms are used widely in medicine.21 A useful nomogram will provide effective assistance to clinical doctors due to its user-friendly interface and good predictive performance.22 In our previous work, we have constructed and validated a diagnostic nomogram to differentiate between epididymal tuberculosis and bacterial epididymitis.23 We have found that early diagnosis of RTB is also difficult in clinical practice. Given the numerous similarities in the clinical manifestations between RTB and nontuberculous renal infection, better diagnostic tools to differentiate them must be developed. Therefore, we constructed a nomogram to distinguish between RTB and nontuberculous renal infection to help clinicians make judgments while diagnosing RTB.

    The nomogram contained five variables: previous TB history, CRP levels, fever, chronic infection and hydronephrosis. In this study, we screened these variables through univariate and multivariate regression analysis. The nomogram was evaluated by C-index, calibration curves and DCA. In this study, the nomogram was used in the derivation cohort, the C-index was 0.99 (95% CI = 0.97–1.00), whereas in the validation cohort, the C-index was 0.98 (95% CI = 0.96–1.01), previous studies have shown that a C-index > 0.75 indicates that the model has high accuracy. The results confirmed the clinical feasibility of the model. Because our model was based on certain common clinical characteristics, laboratory examination results and imaging examination results, it is particularly suitable for application in primary hospitals and underdeveloped areas. Especially for medical institutions lacking rapid detection technologies such as molecular biology testing, it will be beneficial for early screening of RTB.

    There are some limitations in our study. This study was a retrospective study not a prospective study and this study lacked validation of external data. Retrospective studies rely on existing clinical data, but such databases are not specifically designed for clinical research, so in most cases, it is inevitable that some data will be missing; In addition, some variables that may affect the outcome may not have been collected at all. The number of patients included was small, especially for patients with nontuberculous renal infection. We used univariable and multivariable logistic regression analysis to evaluate the variables. However, it may result in some clinically significant variables being excluded from the model. Thus, a prospective study with a large sample size is warranted. The inclusion of more cases will help in constructing a more reasonable model that can distinguish between RTB and nontuberculous renal infection.

    Conclusions

    In this retrospective study, we constructed and validated a diagnostic nomogram to differentiate between RTB and nontuberculous renal infection. This nomogram incorporated common demographics, clinical characteristics, laboratory examination parameters and imaging examination results of patients with epididymal TB. The results reveal that this nomogram exhibit good discrimination and calibration. Furthermore, DCA showed that a net benefit is achieved when the proposed nomogram is used to differentiate between RTB and nontuberculous renal infection. This nomogram may be of great value for distinguishing between RTB and nontuberculous renal infection.

    Abbreviations

    MTB, Mycobacterium tuberculosis; RTB, renal tuberculosis; TB, tuberculosis; PTB, pulmonary tuberculosis; EPTB, extrapulmonary tuberculosis; UGTB, urogenital tuberculosis; AFB, acid-fast bacilli; LUTS, lower urinary tract symptoms; DCA, decision curve analysis; ROC, receiver operating characteristic; AUC, area under the curve.

    Data Sharing Statement

    The datasets used and/or analyzed during the current study are available from the corresponding author on reasonable request.

    Ethics Approval and Consent to Participate

    This study complied with the declaration of Helsinki and this study was approved by the Human Research Ethics Committee of Hangzhou Red Cross Hospital (No: 2023-096). Informed consent was waived owing to the retrospective nature of the study and was approved by the Human Research Ethics Committee of Hangzhou Red Cross Hospital. In this study, we respected and protected the rights and privacy of participants, and ensured the confidentiality of their personal information.

    Author Contributions

    All authors made a significant contribution to the work reported, whether that is in the conception, study design, execution, acquisition of data, analysis and interpretation, or in all these areas; took part in drafting, revising or critically reviewing the article; gave final approval of the version to be published; have agreed on the journal to which the article has been submitted; and agree to be accountable for all aspects of the work.

    Funding

    This study was funded by Hangzhou Science and Technology Bureau (2023WJC090).

    Disclosure

    The authors declare that they have no competing interests in this work.

    References

    1. Chakaya J, Khan M, Ntoumi F, et al. Global tuberculosis report 2020 – reflections on the global TB burden, treatment and prevention efforts. Int J Infect Dis. 2021;113 Suppl 1(Suppl 1):S7–s12. doi:10.1016/j.ijid.2021.02.107

    2. Chakaya J, Petersen E, Nantanda R, et al. The WHO global tuberculosis 2021 report – not so good news and turning the tide back to end TB. Int J Infect Dis. 2022;124 Suppl 1:S26–s9. doi:10.1016/j.ijid.2022.03.011

    3. Kulchavenya E, Kholtobin D, Shevchenko S. Challenges in urogenital tuberculosis. World J Urol. 2020;38(1):89–94. doi:10.1007/s00345-019-02767-x

    4. Toccaceli S, Persico Stella L, Diana M, et al. Renal tuberculosis: a case report. G Chir. 2015;36(2):76–78.

    5. Psihramis KE, Donahoe PK. Primary genitourinary tuberculosis: rapid progression and tissue destruction during treatment. J Urol. 1986;135(5):1033–1036. doi:10.1007/s10096-020-04052-x

    6. Alvarez S, McCabe WR. Extrapulmonary tuberculosis revisited: a review of experience at Boston City and other hospitals. Medicine. 1984;63(1):25–55. [PMID: 6419006]. doi:10.1097/00005792-198401000-00003

    7. Gokalp A, Gultekin EY, Ozdamar S. Genito-urinary tuberculosis: a review of 83 cases. Br J Clin Pract. 1990;44(12):599–600. [PMID: 2102154]. doi:10.1111/j.1742-1241.1990.tb10113.x

    8. Hemal AK, Gupta NP, Rajeev TP, Kumar R, Dar L, Seth P. Polymerase chain reaction in clinically suspected genitourinary tuberculosis: comparison with intravenous urography, bladder biopsy, and urine acid fast bacilli culture. Urology. 2000;56(4):570–574. doi:10.1016/s0090-4295(00)00668-3

    9. Liu P, Wang Y, Hao S, Qin Y. Comparison of the CapitalBio™Mycobacterium RT-PCR detection test and Xpert MTB/RIF assay for diagnosis of renal tuberculosis. Eur J Clin Microbiol Infect Dis. 2021;40(3):559–563. doi:10.1007/s10096-020-04052-x

    10. Ghaleb K, Afifi M, El-Gohary M. Assessment of diagnostic techniques of urinary tuberculosis. Mediterr J Hematol Infect Dis. 2013;5(1):e2013034. doi:10.4084/mjhid.2013.034

    11. Alberti KG, Zimmet PZ. Definition, diagnosis and classification of diabetes mellitus and its complications. Part 1: diagnosis and classification of diabetes mellitus provisional report of a WHO consultation. Diabet Med. 1998;15(7):539–553. doi:10.1002/(sici)1096-9136(199807)15:7<539::Aid-dia668>3.0.Co;2-s

    12. Figueiredo AA, Lucon AM, Junior RF, Srougi M. Epidemiology of urogenital tuberculosis worldwide. Int J Urol. 2008;15(9):827–832. doi:10.1111/j.1442-2042.2008.02099.x

    13. Cek M, Lenk S, Naber KG, et al. EAU guidelines for the management of genitourinary tuberculosis. Eur Urol. 2005;48(3):353–362. doi:10.1016/j.eururo.2005.03.008

    14. Scott LE, Beylis N, Nicol M, et al. Diagnostic accuracy of Xpert MTB/RIF for extrapulmonary tuberculosis specimens: establishing a laboratory testing algorithm for South Africa. J Clin Microbiol. 2014;52(6):1818–1823. doi:10.1128/jcm.03553-13

    15. Figueiredo AA, Lucon AM, Srougi M. Urogenital Tuberculosis. Microbiol Spectr. 2017;5(1). doi:10.1128/microbiolspec.TNMI7-0015-2016

    16. Waman VP, Vedithi SC, Thomas SE, et al. Mycobacterial genomics and structural bioinformatics: opportunities and challenges in drug discovery. Emerg Microbes Infect. 2019;8(1):109–118. doi:10.1080/22221751.2018.1561158

    17. Boehme CC, Nabeta P, Hillemann D, et al. Rapid molecular detection of tuberculosis and rifampin resistance. N Engl J Med. 2010;363(11):1005–1015. doi:10.1056/NEJMoa0907847

    18. Chen Y, Wu P, Fu L, Liu YH, Zhang Y, Zhao Y. Multicentre evaluation of Xpert MTB/RIF assay in detecting urinary tract tuberculosis with urine samples. Sci Rep. 2019;9(1):11053. doi:10.1038/s41598-019-47358-3

    19. Samuel BP, Michael JS, Chandrasingh J, Kumar S, Devasia A, Kekre NS. Efficacy and role of Xpert(®) Mycobacterium tuberculosis/rifampicin assay in urinary tuberculosis. Indian J Urol. 2018;34(4):268–272. doi:10.4103/iju.IJU_189_18

    20. Joshi H, Kandari D, Maitra SS, Bhatnagar R. Biosensors for the detection of Mycobacterium tuberculosis: a comprehensive overview. Crit Rev Microbiol. 2022;48(6):784–812. doi:10.1080/1040841X.2022.2035314

    21. Nieder C, Mehta MP, Geinitz H, Grosu AL. Prognostic and predictive factors in patients with brain metastases from solid tumors: a review of published nomograms. Crit Rev Oncol Hematol. 2018;126:13–18. doi:10.1016/j.critrevonc.2018.03.018

    22. Wu L, Dai X, Wang H, et al. Prediction of the complication risk in drug-resistant tuberculosis after surgery: development and assessment of a novel nomogram. Front Surg. 2021;8:689742. doi:10.3389/fsurg.2021.689742

    23. Liu P, Cai G, Gu H, Qin Y. Diagnostic nomogram to differentiate between epididymal tuberculosis and bacterial epididymitis. Infection. 2023;51(2):447–454. doi:10.1007/s15010-022-01916-6

    Continue Reading

  • All Songs Considered : NPR

    All Songs Considered : NPR

    Malice and Pusha T of Clipse.

    Cian Moore


    hide caption

    toggle caption

    Cian Moore

    It’s Friday, and as of the stroke of midnight, following a 16-year absence, Clipse has returned. Malice and Pusha T have released a number of solo projects since that time, but the rap duo made up of two brothers from Virginia Beach is finally back together with new album, Let God Sort Em Out, and we can’t help but be excited.

    But that’s not the only major comeback from a beloved duo today. The Swell Season — the pairing of Glen Hansard and Markéta Irglová, the Oscar-winning stars of the 2007 film Once — has released Forward, which also happens to be that band’s first album in 16 years.

    NPR Music’s Stephen Thompson and WNXP’s Celia Gregory dive into these two albums, plus Wet Leg’s knockout sophomore record and a few more releases on this new music Friday.

    The Starting Five

    Wet Leg

    Wet Leg.

    Alice Backham


    hide caption

    toggle caption

    Alice Backham

    Our hosts share the backstory and best songs on the following albums:

    💿 Wet Leg, moisturizer

    💿 The Swell Season, Forward

    💿 Clipse, Let God Sort Em Out

    💿 Allo Darlin’, Bright Nights

    💿 Burna Boy, No Sign of Weakness

    New Music Friday is a feature of NPR’s All Songs Considered podcast. Hear the discussion on the NPR AppAppleSpotify or wherever you get your podcasts.

    The Lightning Round

    Open Mike Eagle

    Open Mike Eagle

    Robert Adam Mayer


    hide caption

    toggle caption

    Robert Adam Mayer

    Five more albums we wish we had time to discuss on the podcast:

    💿 Ólafur Arnalds & Talos, A Dawning

    💿 Martha, Standing Where It All Began – Singles and B-Sides 2012-2025

    💿 Open Mike Eagle, Neighborhood Gods Unlimited

    💿 Petey USA, The Yips

    💿 Tony Njoku, All Our Knives Are Always Sharp

    Listen to each album’s best songs on our New Music Friday playlists on Spotify and Apple, or wherever you stream music.

    The Long List

    Allo Darlin

    Allo Darlin

    Jørgen Nordby


    hide caption

    toggle caption

    Jørgen Nordby

    For those who want to dig even deeper, here are the week’s new albums sorted by genre:

    Rap/Hip-Hop

    • 81355 (BLESS), Bad Dogs
    • Che, Rest In Bass
    • Saekyi, LOST IN AMERICA
    • Loe Shimmy, Rockstar Junkie

    Electronic/Out There

    • Charlotte De Witte, Charlotte De Witte
    • Jackie-O Motherf*****, Flags of the Sacred Harp (20th Anniversary)
    • Leo Luchini, Slug It Out
    • Lewis Fautzi, Unwritten Chapters
    • Midwife + Matt Jencik, Never Die
    • Molly Joyce, State Change
    • Nicolas Bougaïeff, Sunday Summer
    • Raz Ohara, Memories Of Tomorrow
    • Reid Willis, Reliquary
    • Rollo Doherty, Strings EP
    • Sarah Sommers, VIVID
    • North Not South, Shifting Dunes EP
    • Marina Mello, Deságua
    • Barry Can’t Swim, Loner
    • Patricia Wolf, Hrafnamynd

    Global

    • Africa Express, Africa Express presents… Bahidorá
    • Paloma Mami, CODiGOS DE MUNEKA
    • Plunky & Oneness of Juju, Made Through Ritual

    Jazz

    • Dom Salvador, DOM SALVADOR JID024
    • Olga Amelchenko, Howling Silence
    • Qur’an Shaheed, Pulse
    • Dino Saluzzi, El Viejo Caminante
    • Fuubutsushi, Columbia Deluxe
    • Kokoroko, Tuff Times Never Last
    • Nate Mercereau, Josh Johnson and Carlos Niño, Openness Trio

    Pop

    • Cian Ducrot, Little Dreaming
    • Dean Lewis, The Epilogue (Deluxe)
    • Fly By Midnight, The Fastest Times of Our Lives
    • Petey USA, The Yips
    • Jessica Winter, My First Album

    Country/Folk/Americana

    • Brent Cobb & The Fixin’s, Ain’t Rocked in a While
    • Sam Williams, Act II: COUNTRYSTAR
    • Tami Neilson, Neon Cowgirl
    • Tanner Usrey, These Days
    • Winterpills, Winterpills (20th Anniversary Edition)
    • Ketch Secor, Story The Crow Told Me
    • Murry Hammond, Trail Songs of the Deep
    • Noah Cyrus, I WANT MY LOVED ONES TO GO WITH ME
    • Poor Creature, All Smiles Tonight
    • The Wildmans, Longtime Friend

    R&B/Soul

    • Alina Bzhezhinska & Tulshi, Whispers of Rain
    • GIVĒON, BELOVED
    • Harvey Scales, Trying To Survive (Reissue)
    • Leroi Conroy, A Tiger’s Tale

    Rock/Alt/Indie

    • Brutus VIII, Do It For the Money
    • Cosmorat, POOSHKA
    • Flooding, Object 1
    • Half Japanese, Adventure
    • Jethro Tull, Still Living in the Past (5xCD)
    • Joey Waronker & Pete Min, King King
    • Mark Stewart, The Fateful Symmetry
    • N8NOFACE & Chico Mann, As Of Right Now
    • Pat Hatt, Pat Hatt
    • Somerset Thrower, Take Only What You Need to Survive
    • Split Chain, motionblur
    • The Kinks, The Journey Part 3
    • Vinnie Stigma, The Outlaw Vinnie Stigma
    • Aunt Katrina, This Hear is Slowly Killing Me
    • Autocamper, What Do You Do All Day?
    • Gina Birch, Trouble
    • Gwenno, Utopia
    • Jake Minch, George
    • Mal Blum, The Villain
    • Midnight Rodeo, Chaos Era
    • Mike Polizze, Around Sound
    • Sister., Two Birds
    • sunking, I DON’T LIKE MY TELEPHONE

    Credits

    • Host: Stephen Thompson
    • Guest: Celia Gregory, WNXP
    • Producer: Simon Rentner
    • Editor: Otis Hart
    • Executive Producer: Suraya Mohamed

    Continue Reading

  • Study Finds Running-Related Overuse Injuries Often Occur Abruptly During Single Training Sessions – geneonline.com

    Study Finds Running-Related Overuse Injuries Often Occur Abruptly During Single Training Sessions – geneonline.com

    1. Study Finds Running-Related Overuse Injuries Often Occur Abruptly During Single Training Sessions  geneonline.com
    2. This Study Just Overturned Everything We Thought We Knew About Running Injuries  SciTechDaily
    3. Too Much Data About Your Biomechanics Could Hurt You (Literally)—Here’s Why  RUN | Powered by Outside

    Continue Reading

  • Mix Tape — cassette sparks a love story spanning decades and continents – Financial Times

    Mix Tape — cassette sparks a love story spanning decades and continents – Financial Times

    1. Mix Tape — cassette sparks a love story spanning decades and continents  Financial Times
    2. Mix Tape review: this Binge series is resonant and real  ScreenHub Australia
    3. Nostalgic and “intoxicating” drama with “unforgettable ’80s” vibes confirms BBC release date  Digital Spy
    4. ‘It’s the new One Day’: Mix Tape is the BBC’s new romantic drama starring Bridgerton’s Florence Hunt  Cosmopolitan
    5. One Day meets High Fidelity: Mix Tape will be the “nostalgic” BBC drama of the summer  Red magazine

    Continue Reading

  • WPP turns to Microsoft executive as AI threatens ‘Kodak moment’ – Financial Times

    WPP turns to Microsoft executive as AI threatens ‘Kodak moment’ – Financial Times

    1. WPP turns to Microsoft executive as AI threatens ‘Kodak moment’  Financial Times
    2. Chief Executive Officer Appointment  WPP companies
    3. WPP names Cindy Rose CEO; £1.25m salary unveiled, Mark Read to exit | WPP SEC Filing – Form 6-K  Stock Titan
    4. WPP taps Microsoft exec Rose to rebuild ad group  MarketScreener
    5. FTSE 100 today: Stocks higher while pound holds at $1.36; WPP appoints new CEO  Investing.com

    Continue Reading

  • How Africa’s independence movements found their voice in a corner of Manchester – Financial Times

    How Africa’s independence movements found their voice in a corner of Manchester – Financial Times

    1. How Africa’s independence movements found their voice in a corner of Manchester  Financial Times
    2. Liberation review – fizzing tensions of historic Pan-African Congress  The Guardian
    3. Organising to fight colonialism  Morning Star | The People’s Daily
    4. Review: Liberation (Manchester International Festival)  jadar.uk
    5. Liberation at the Royal Exchange Theatre: wonderfully alive  The Stage

    Continue Reading

  • Commodity firms poised for $300mn windfall from US copper tariff trade – Financial Times

    Commodity firms poised for $300mn windfall from US copper tariff trade – Financial Times

    1. Commodity firms poised for $300mn windfall from US copper tariff trade  Financial Times
    2. Five Things to Know About Record Copper Prices – WSJ  The Wall Street Journal
    3. Trump sets 50% US tariffs on copper, Brazilian imports starting in August  Reuters
    4. Chile and Mexico prepare to redirect copper exports after U.S. tariff plan  Profit by Pakistan Today
    5. EC President von der Leyen: Working non-stop to find an initial agreement with the US  FXStreet

    Continue Reading